Ovarian Cancer Australia prides itself on being visionary, persistent and leading by example; advocating for those affected by working collaboratively to make ovarian cancer a national priority.
Why we advocate for change
Ovarian cancer has the lowest survival rate of any women’s cancer. In Australia, the overall five-year survival rate for women diagnosed with ovarian cancer is 46 per cent. In comparison, the overall five-year survival rate for women diagnosed with breast cancer is 91 per cent.
Ovarian cancer receives less than 25 per cent of the funding of other, less deadly cancers. Expenditure data published by the National Health and Medical Research Council (NHMRC) reveals that, between 2014 and 2018, ovarian cancer received four times less funding for research than breast cancer and around half that of prostate cancer.
Ovarian Cancer Australia leads the National Action Plan, a road map designed to improve sector collaboration and help fast-track better outcomes for women living with ovarian cancer. The National Action Plan is used to advocate for; and guide; increased research funding. OCA also leads psycho-social research for ovarian cancer and uses learnings to continually improve outcomes for those affected.